z-logo
open-access-imgOpen Access
The Regulation of Leukemia Inhibitory Factor
Author(s) -
Xuetian Yue,
Lihua Wu,
Wenwei Hu
Publication year - 2015
Publication title -
cancer cell and microenvironment
Language(s) - English
Resource type - Journals
ISSN - 2331-0928
DOI - 10.14800/ccm.877
Subject(s) - leukemia inhibitory factor , stat3 , cytokine , pi3k/akt/mtor pathway , biology , cancer research , microbiology and biotechnology , leukemia , embryonic stem cell , signal transduction , estrogen , interleukin 6 , immunology , endocrinology , gene , biochemistry
Leukemia inhibitory factor (LIF), a secreted cytokine, plays an important role in a wide array of biological processes including inducing differentiation of leukemia cell, inflammatory response, neuronal development, embryonic implantation, stem cell self-renewal and cancer progression, etc. LIF exerts its biological functions mainly through the activation and regulation of JAK/STAT3, AKT, EKR1/2 and mTOR signal pathways. The expression levels of LIF are regulated by many different factors under different conditions in different tissue/cell types. For example, estrogen and p53 are important regulators for the high LIF production in uterine tissues at the implantation stage. Hypoxia plays a critical role in LIF overexpression in solid tumors. Many cytokines, including IL-6, IL-1β, can also induce the LIF expression and production. In this review, we summarize the current understanding on the transcriptional regulation of LIF under various conditions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom